Cohen Milstein Reminds Zenas BioPharma (ZBIO) Investors of Opportunity to Lead Securities Fraud Suit

/EIN News/ -- WASHINGTON, May 05, 2025 (GLOBE NEWSWIRE) -- Cohen Milstein Sellers & Toll PLLC, a nationally recognized leader in investor protection, announces that investors who purchased shares of Zenas BioPharma, Inc. (NASDAQ: ZBIO) in the company’s September 2024 initial public offering may seek to lead a federal securities class action. The deadline to move for appointment as lead plaintiff is June 16, 2025.

[Click here for information about joining the class action]

If you’d like to discuss this matter or your rights before signing up, please contact Molly J. Bowen, a partner at Cohen Milstein, at (202) 408-4600 or mbowen@cohenmilstein.com.

The Lawsuit
Filed in the U.S. District Court for the District of Massachusetts, the complaint alleges that Zenas and its IPO underwriters misrepresented the company’s financial outlook. Zenas BioPharma stated in its IPO materials that it could fund operations for 24 months. However, just weeks later, its Q3 2024 filing disclosed a funding window of only 12 months—cutting projections in half. ZBIO stock fell nearly 49%, closing at $8.72 on April 15, 2025.

Why Lead Plaintiff Matters
Investors with substantial losses can help guide and direct the litigation. Serving as lead plaintiff enables shareholders to influence litigation strategy and potential recovery. Serving in this role is not required to participate in any eventual settlement.

About Cohen Milstein
Cohen Milstein has a national reputation for excellence in securities litigation, recovering billions for investors, including a recent $1 billion settlement in In re Wells Fargo Securities Litigation. The firm is recognized annually by The Legal 500, Chambers USA, and Law360 for its leadership in complex securities class actions.

CONTACT:
Molly Bowen, Esq.
Licensed in DC, Florida, and Ohio
Cohen Milstein Sellers & Toll PLLC
1100 New York Avenue, N.W., Fifth Floor
Washington, D.C. 20005
Phone: (888) 240-0775 or (202) 408-4600
Email: mbowen@cohenmilstein.com
Website: www.cohenmilstein.com

Attorney Advertising. Prior results do not guarantee a similar outcomes.